{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:01:53Z","timestamp":1773277313170,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19ek109224h"],"award-info":[{"award-number":["JP19ek109224h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ymgme.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T11:41:04Z","timestamp":1592998864000},"page":"262-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy"],"prefix":"10.1016","volume":"130","author":[{"given":"Saori","family":"Miwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako M.","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohta","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.06.007_bb0005","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.70.7.2134","article-title":"The defect in the hunter syndrome: deficiency of sulfoiduronate sulfatase","volume":"70","author":"Bach","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0010","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","author":"Neufeld","year":"2014"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0015","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","article-title":"Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - neurological signs and symptoms","volume":"122S","author":"Shapiro","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2017.10.007","article-title":"Treatment of brain disease in the mucopolysaccharidoses","volume":"122s","author":"Scarpa","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.09.013","article-title":"Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice","volume":"111","author":"Akiyama","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2014.11.002","article-title":"Activities of daily living in patients with hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation","volume":"114","author":"Tanjuakio","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2012.05.005","article-title":"Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II","volume":"107","author":"Higuchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1601-183X.2008.00413.x","article-title":"Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice","volume":"7","author":"Mader","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2015.03.002","article-title":"Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice","volume":"115","author":"Beard","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/gim.2015.36","article-title":"A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II","volume":"18","author":"Muenzer","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2016.08.025","article-title":"Targeting blood-brain-barrier transcytosis - perspectives for drug delivery","volume":"120","author":"Mager","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0090","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","article-title":"Iduronate-2-Sulfatase with anti-human transferrin receptor antibody for neuropathic mucopolysaccharidosis II: a phase 1\/2 trial","volume":"27","author":"Okuyama","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0110","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1089\/hum.2016.101","article-title":"Delivery of an Adeno-associated virus vector into cerebrospinal fluid attenuates central nervous system disease in mucopolysaccharidosis type II mice","volume":"27","author":"Hinderer","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0115","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of neurocognitive deficiency in mucopolysaccharidosis type II mice by central nervous system-directed, AAV9-mediated iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.omtm.2018.07.005","article-title":"Targeting root cause by systemic scAAV9-hIDS gene delivery: functional correction and reversal of severe MPS II in mice","volume":"10","author":"Fu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/hum.2013.238","article-title":"Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I\/II trial","volume":"25","author":"Tardieu","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0130","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(17)30169-2","article-title":"Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1\/2 clinical trial","volume":"16","author":"Tardieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0135","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ymthe.2018.03.002","article-title":"Dose-dependent prevention of metabolic and neurologic disease in murine MPS II by ZFN-mediated in vivo genome editing","volume":"26","author":"Laoharawee","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymthe.2018.10.018","article-title":"ZFN-mediated in vivo genome editing corrects murine hurler syndrome","volume":"27","author":"Ou","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nbt1018-907","article-title":"Sangamo\u2019s landmark genome editing trial gets mixed reception","volume":"36","author":"Sheridan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0150","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.V90.3.986","article-title":"Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model","volume":"90","author":"Kennedy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0155","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2005-03-1189","article-title":"Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology","volume":"106","author":"Sano","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/hum.2014.158","article-title":"Hematopoietic stem cell gene therapy corrects neuropathic phenotype in murine model of mucopolysaccharidosis type II","volume":"26","author":"Wakabayashi","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0175","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0180","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0185","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0190","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2003-05-1432","article-title":"Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging","volume":"102","author":"Wang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virusres.2014.11.027","article-title":"MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors","volume":"196","author":"Roth","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0200","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2005-03-1172","article-title":"Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen","volume":"107","author":"Mitsuhashi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0205","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1182\/blood-2010-07-295949","article-title":"Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice","volume":"116","author":"Xue","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ymgme.2016.08.003","article-title":"Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II","volume":"119","author":"Yokoi","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0215","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/mt.2012.136","article-title":"Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression","volume":"20","author":"Falahati","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0220","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","article-title":"Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods","volume":"9","author":"Sastry","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0225","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.mt.6300180","article-title":"Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression","volume":"15","author":"Kimura","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ymgme.2015.05.009","article-title":"A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice","volume":"117","author":"Shimada","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0235","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2017.12.428","article-title":"Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II","volume":"123","author":"Hoshina","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jnc.13379","article-title":"SAD-B kinase regulates pre-synaptic vesicular dynamics at hippocampal Schaffer collateral synapses and affects contextual fear memory","volume":"136","author":"Watabe","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0245","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0250","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0255","doi-asserted-by":"crossref","first-page":"227ra233","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0260","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2006.11.006","article-title":"Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B","volume":"90","author":"Ryazantsev","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s004010050629","article-title":"Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in batten disease and in unrelated lysosomal disorders","volume":"93","author":"Elleder","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0270","first-page":"101","article-title":"P-tau and subunit c mitochondrial ATP synthase accumulation in the central nervous system of a woman with hurler-Scheie syndrome treated with enzyme replacement therapy for 12 years","volume":"41","author":"Kobayashi","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0275","doi-asserted-by":"crossref","first-page":"14870","DOI":"10.1073\/pnas.1416660111","article-title":"Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type","volume":"111","author":"Kan","year":"2014","journal-title":"IIIB Proc.Nat. Acad. Sci. United States Am."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062506","article-title":"Contribution of bone marrow-derived hematopoietic stem\/progenitor cells to the generation of donor-marker(+) cardiomyocytes in vivo","volume":"8","author":"Fukata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0285","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0290","article-title":"Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy","volume":"8","author":"Akanksha Chhabra","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0295","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.1205858109","article-title":"Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation","volume":"109","author":"Capotondo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0300","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/mt.2013.29","article-title":"Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation","volume":"21","author":"Wilkinson","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1410-y","article-title":"Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours","volume":"16","author":"Youshani","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077632","article-title":"Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier","volume":"8","author":"Langford-Smith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.06.007_bb0315","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/hum.2019.016","article-title":"Assessing the impact of cyclosporin A on lentiviral transduction and preservation of human hematopoietic stem cells in clinically relevant ex vivo gene therapy settings","volume":"30","author":"Petrillo","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0320","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ymthe.2017.09.025","article-title":"Prostaglandin E2 increases lentiviral vector transduction efficiency of adult human hematopoietic stem and progenitor cells","volume":"26","author":"Heffner","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.06.007_bb0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.omtm.2019.01.005","article-title":"High-efficiency lentiviral transduction of human CD34(+) cells in high-density culture with poloxamer and prostaglandin E2","volume":"13","author":"Uchida","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:49Z","timestamp":1761089149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1096719220301463"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.007","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}